The Global Divide: Why Private Healthcare Abroad Outshines the American System

The US private healthcare system is expensive relative to its outcomes. According to OECD data, the United States spends nearly twice the per capita average of wealthy nations on healthcare. Life expectancy and chronic disease management metrics do not reflect this spending advantage. This cost gap has made healthcare access a factor in citizenship and residency investment decisions.

The American Anomaly: High Cost For Average Outcomes

US healthcare costs are driven by for-profit provider networks, pharmaceutical pricing, private insurance intermediaries and administrative overhead. The Commonwealth Fund has reported that among insured Americans, nearly a quarter are underinsured, meaning deductibles and co-pays could still produce large medical debts.

In countries with universal public systems, private healthcare operates in a regulated environment. The public option anchors pricing and prevents the cost escalation seen in the US. The SIP Health Cost Index 2025 ranks the US as the most expensive private healthcare market, with average annual international private medical insurance at $17,969.

The Global Value Proposition: Quality and Affordability

Private healthcare in many European countries provides rapid-access specialist care that complements the public system. Clinical quality in these countries is comparable to or exceeds the US, with a greater emphasis on primary and preventative care. This is reflected in higher life expectancy figures across comparable nations.

Citizenship By Investment: A Prescription for Global Health Security

The cost gap in private healthcare has made residency and citizenship planning partly a healthcare decision. Citizenship by investment and Golden Visa programs allow individuals to obtain residency or citizenship through investment in the host country.

Investors use these programs to gain:

1. Access to national healthcare systems through legal residency.

2. Access to lower-cost private healthcare markets.

3. Medical mobility within the EU through a second passport, allowing treatment at specialized centers across member states without visa requirements.

Examples of CBI and Residence Programs for Healthcare Access

Portugal Golden Visa: Residency grants access to Portugal's national health service. The country has JCI-accredited private hospitals at costs well below US equivalents.

Italy Golden Visa: Residency includes access to Italy's public healthcare system. Both programs provide access to other EU member states.

A second citizenship functions as a hedge against the financial risk of the US system. It provides residency in a jurisdiction where healthcare costs are regulated and predictable.

Conclusion

The US healthcare cost structure is an outlier among wealthy nations. Private healthcare abroad, particularly in countries with strong public systems, costs less while delivering comparable clinical outcomes. Citizenship by investment programs provide a way to access these systems on a permanent basis.